nifuroxazide Tablets 100 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Status OTC Available pack sizes: 100 mg - 24 tablets, 200 mg - 12 tablets. Indication Acute or chronic diarrhea in the course of bacterial infections of the gastrointestinal tract Classification Generic
Manufacturer #279
This company is a leading manufacturer of drugs, dietary supplements, cosmetics, and medical devices with nearly 40 years of experience. They produce high-quality products to meet the health needs of patients, delivering over 48 million packages annually. The company prides itself on its Polish heritage, being one of the few family-owned pharmaceutical companies with entirely local capital. They aim to be a leader in the pharmaceutical industry, focusing on quality, innovation, and customer satisfaction. The company values honesty, responsibility, high standards, flexibility, openness to solutions, and continuous development, employing over 1,500 people in Lower Silesia.

Manufacturer usually replies in 12 days

None